TGFB1 and scleroderma: TIMP-3 gene expression is also upregulated in human scleroderma fibroblasts, and it is further enhanced by TGF-β, suggesting that TIMP-3 as an ECM component is involved in the pathogenesis of dermal fibrosis [15].